Table 2 Multivariate analysis of variables associated with in-hospital mortality in all study patients
Variable | Survivors (n = 520) | Non-survivors (n = 192) | P value | AOR (95% CI) |
|---|---|---|---|---|
Age (y) |  |  |  < 0.001 | 4.320 (2.687–6.947) |
 < 65, n (%) | 283 (54.4) | 31 (16.1) |  |  |
 ≥ 65, n (%) | 237 (45.6) | 161 (83.9) |  |  |
Sex |  |  | 0.298 | 0.795 (0.517–1.224) |
 Female, n (%) | 149 (28.7) | 83 (43.2) |  |  |
 Male, n (%) | 371 (71.3) | 109 (56.8) |  |  |
DM |  |  | 0.229 | 1.317 (0.841–2.063) |
 No, n (%) | 387 (74.4) | 109 (56.8) |  |  |
 Yes, n (%) | 133 (25.6) | 83(43.2) |  |  |
History of smoking |  |  | 0.364 | 1.317 (0.798–1.853) |
 No, n (%) | 208 (40.0) | 96 (50.0) |  |  |
 Yes, n (%) | 312 (60.0) | 96 (50.0) |  |  |
FPG (mmol/L) |  |  |  < 0.001 | 2.319 (1.564–3.438) |
 < 6.1, n (%) | 302 (58.1) | 65 (33.9) |  |  |
 ≥ 6.1, n (%) | 218 (41.9) | 127 (66.1) |  |  |
Triglycerides (mmol/L) |  |  | 0.184 | 0.739 (0.472–1.155) |
 < 1.8, n (%) | 326 (62.7) | 142 (74.0) |  |  |
 ≥ 1.8, n (%) | 194 (37.3) | 50 (26.0) |  |  |
TC (mmol/L) |  |  | 0.689 | 1.194 (0.502–2.843) |
 < 6.6, n (%) | 490 (94.2) | 180 (93.7) |  |  |
 ≥ 6.6, n (%) | 30 (5.8) | 12 (6.3) |  |  |
AST (U/L) |  |  | 0.764 | 1.075 (0.671–1.722) |
 < 2 ULN, n (%) | 237 (45.6) | 79 (41.1) |  |  |
 ≥ 2 ULN, n (%) | 283 (54.4) | 113 (58.9) |  |  |
ALT (U/L) |  |  | 0.002 | 2.240 (1.331–3.771) |
 < 2 ULN, n (%) | 432 (83.1) | 140 (72.9) |  |  |
 ≥ 2 ULN, n (%) | 88 (16.9) | 52 (27.1) |  |  |
GGT (U/L) |  |  | 0.643 | 1.161 (0.618–2.182) |
 < 2 ULN, n (%) | 468 (90.0) | 163 (84.9) |  |  |
 ≥ 2 ULN, n (%) | 52 (10.0) | 29 (15.1) |  |  |
D-dimer (ng/mL) |  |  |  < 0.001 | 2.117 (1.407–3.184) |
 < 400, n (%) | 374 (71.9) | 67 (34.9) |  |  |
 ≥ 400, n (%) | 146 (28.1) | 125 (65.1) |  |  |
Tn I (ng/mL) |  |  | 0.736 | 0.929 (0.604–1.429) |
 < 2.5, n (%) | 266 (51.2) | 87 (45.3) |  |  |
 ≥ 2.5, n (%) | 254 (48.8) | 105 (54.7) |  |  |
Fibrinogen (g/L) |  |  | 0.020 | 1.601 (1.077–2.380) |
 < 3.5, n (%) | 289 (55.6) | 73 (38.0) |  |  |
 ≥ 3.5, n (%) | 231 (44.4) | 119 (62.0) |  |  |
eGFR (mL/min/1.73 m2) |  |  |  < 0.001 | 2.279 (1.519–3.419) |
 ≥ 90, n (%) | 373 (71.7) | 65 (33.9) |  |  |
 < 90, n (%) | 147 (28.3) | 127 (66.1) |  |  |